- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
---|---|---|---|---|---|---|
Associate Sales Manager | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Jul 17, 2024 |
(Sr.) Sales Executive-Solid Tumor | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Jul 02, 2024 |
(Sr.) Sales Executive-OPH | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Jun 12, 2024 |
(Sr.) Sales Executive-CRM HA team | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Sales | Jun 12, 2024 |
Marketing Manager | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Marketing | May 27, 2024 |
Associate Product Manager | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Commercial & General Management | Apr 21, 2024 |
Clinical Research Associate | Hong Kong | Hong Kong Special Administrative Region, China | Development | Innovative Medicines | Research & Development | Apr 17, 2024 |
Medical Science Liaison – Cardio-Renal-Metabolic | Hong Kong | Hong Kong Special Administrative Region, China | International | Innovative Medicines | Research & Development | Apr 16, 2024 |
(Associate) Product Manager | Hong Kong | Hong Kong Special Administrative Region, China | International | China IMI | Commercial & General Management | Mar 13, 2024 |
Marketing Manager | Hong Kong | Hong Kong Special Administrative Region, China | International | China IMI | Marketing | Feb 29, 2024 |
(Sr.) Product Manager | Hong Kong | Hong Kong Special Administrative Region, China | International | China IMI | Marketing | Feb 27, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى